Blog Layout

NCI's new Deputy Director for Data Science

Conversation with The Cancer Letter:  NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready” - July 12, 2024

“All research now involves data science at some level.  And I can’t think of some aspect of science where we don’t want to analyze the results.”


What can NCI accomplish in data science?


In the informatics world, the institute’s resources would be considered paltry by comparison with private companies. 

The institute’s total fiscal year 2024 budget of $7.2 billion would constitute less than 25% of the R&D budget of Microsoft Corp. and would be $2.3 billion lower than this year’s research and development spend of the artificial intelligence giant NVIDIA Corp.


“I think maybe the better question is how can we take what is being developed by those companies for really broad use, and how do we bring that into cancer research and make cancer research happen faster, better?” said Warren A. Kibbe, NCI’s inaugural deputy director for data science and strategy.

Kibbe said his primary goals as NCI’s top data scientist include improving access to data, enhancing the scientists’ abilities to apply visualization techniques for cancer research, and using technologies, such as artificial intelligence and machine learning, to advance our understanding of the basic mechanisms and etiology of cancer. 


Over the past seven years, Kibbe served as chief for translational biomedical informatics and professor and vice chair in the Department of Biostatistics and Bioinformatics at Duke University and as the chief data officer for the Duke Cancer Institute.

Prior to that, Kibbe headed the NCI Center for Biomedical Informatics and Information Technology, known as CBIIT, for four years (The Cancer LetterJune 16, 2017; June 26, 2013). At NCI, Kibbe spearheaded development of the Genomic Data Commons, a big data project for comprehensive, raw genomics information (The Cancer LetterApril 29, 2016). 


In addition to consulting across NIH on data science issues during his first stint at NCI, Kibbe played a role in establishing partnerships with the U.S. Department of Energy and was involved in putting together collaborations in precision medicine and the Cancer Moonshot. 

Kibbe is also a co-founder, with Sorena Nadaf-Rahrov, of the Cancer Center Informatics Society (CI4CC). 


“No one is better suited to help the NCI innovate in cancer data science and biomedical informatics than Warren,” Nadaf-Rahrov said to The Cancer Letter. “His background and temperament provide an excellent balance to the needs and vision of the NCI. I look forward to continuing to collaborate with Warren on various projects, both as a long-standing colleague and as the president & CEO of the Cancer Center Informatics Society.”


Link to full article:  https://cancerletter.com/conversation-with-the-cancer-letter/20240712_1/



Share this Article with others

By Sorena Nadaf December 10, 2024
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
By Sorena Nadaf November 11, 2024
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
By Sorena Nadaf October 29, 2024
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
By Sorena Nadaf September 4, 2024
American Cancer Society and Color Health to Provide Free At-Home Colorectal Cancer Screening in Underserved Rural Communities
September 4, 2024
Leading Progress Against Cancer
August 24, 2024
By Drs Karen Knudsen & Othman Laraki.
By Sorena Nadaf July 11, 2024
"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019" American Cancer Society
May 29, 2024
The UCSF Division of Clinical Informatics and Digital Transformation (DoC-IT) and UCSF Health have received a $5 million gift from Ken and Kathy Hao to develop a cutting-edge, real-time, continuous, and automated artificial intelligence (AI) monitoring platform for clinical care. The Impact Monitoring Platform for AI in Clinical Care (IMPACC) aims to bridge the gap between the rapid evolution of AI technologies used by clinicians and the essential need for robust, ongoing assessment of their efficacy, safety, and equity. Julia Adler-Milstein, PhD , chief of the UCSF Division of Clinical Informatics and Digital Transformation (DoC-IT), and Sara Murray, MD, MAS , chief health AI officer at UCSF Health, will lead the pioneering collaboration. “This philanthropic gift is transformative in many ways,” said Adler-Milstein. “It comes at a critical juncture as the healthcare industry more broadly integrates AI into clinical practice. Through IMPACC and this collaborative effort, we are poised to improve patient care at UCSF while advancing the science of how to assess AI tools in real-world use.” Currently, the healthcare field lacks established protocols for ongoing AI monitoring, leading to risks of adverse outcomes for patients and healthcare providers that go undetected. While assessments are conducted to determine the suitability of new AI technologies for safe integration into clinical environments before deployment, once they are deployed, health systems need a way to promptly identify any issues in their real-world performance. IMPACC will fill this urgent need by shifting from planned, periodic, manual monitoring of a focused set of measures to real-time, continuous, automated, and longitudinal monitoring across a broad measure set with specified criteria for escalation to human review and intervention.  Full Article: https://docit.ucsf.edu/news/ucsf-and-ucsf-health-receive-pivotal-donation-support-first-continuous-ai-monitoring-platform
By Sorena Nadaf May 24, 2024
I’m most proud of how my colleagues and I evolved CBIIT’s focus and activities to enable NCI’s scientific mission. My approach had always been to collaborate with colleagues from various NCI divisions, offices, and centers (DOCs). In doing this, we understood each other’s specific needs and ensured that our work together aligned with those needs. This wasn’t always CBIIT’s approach though, and while the change started before I became director, creating the necessary collaborations across the institute and developing the projects to support our scientific partners took consistent and intentional focus. CBIIT has been working closely with the other NCI DOCs for years, supporting individual projects and concerted efforts in major programs (such as the NCI Cancer Research Data Commons [CRDC]), data sharing, and NCI Intramural Research Program data management. In hindsight, I might have tried to initiate this outreach and move these relationships forward more broadly and even more quickly. I also would have ensured that we invested more time and some dedicated funding in innovation. To Article: https://datascience.cancer.gov/news-events/blog/dr-tony-kerlavage-reflects-his-time-nci-cbiit
March 8, 2024
The aims of our case-control study were (1) to develop an automated 3-dimensional (3D) Convolutional Neural Network (CNN) for detection of pancreatic ductal adenocarcinoma (PDA) on diagnostic computed tomography scans (CTs), (2) evaluate its generalizability on multi-institutional public data sets, (3) its utility as a potential screening tool using a simulated cohort with high pretest probability, and (4) its ability to detect visually occult preinvasive cancer on prediagnostic CTs.
Share by: